Holen Sie sich die Stockscreener-App
6.89
0.29%
-0.02
Vorhandelsmarkt:
6.88
-0.010
-0.15%
Schlusskurs vom Vortag:
$6.91
Offen:
$6.9
24-Stunden-Volumen:
605.13K
Relative Volume:
0.31
Marktkapitalisierung:
$562.77M
Einnahmen:
$414.29M
Nettoeinkommen (Verlust:
$-99.81M
KGV:
-5.1618
EPS:
-1.3348
Netto-Cashflow:
$-28.65M
1W Leistung:
-0.14%
1M Leistung:
+0.00%
6M Leistung:
+61.36%
1J Leistung:
-44.26%
1-Tages-Spanne:
$6.89
$6.91
1-Wochen-Bereich:
$6.88
$6.91
52-Wochen-Spanne:
$3.08
$12.24
Accolade Inc Stock (ACCD) Company Profile
Firmenname
Accolade Inc
Sektor
Branche
Telefon
610-834-2989
Adresse
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
Vergleichen Sie ACCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACCD
Accolade Inc
|
6.89 | 562.77M | 414.29M | -99.81M | -28.65M | -1.3348 |
|
VEEV
Veeva Systems Inc
|
229.19 | 37.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
76.68 | 14.39B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
85.71 | 13.49B | 640.44M | -743.28M | -206.93M | -11.29 |
|
SOLV
Solventum Corp
|
73.98 | 12.78B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
HQY
Healthequity Inc
|
113.78 | 9.86B | 1.15B | 96.70M | -161.99M | 1.09 |
Accolade Inc Stock (ACCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-17 | Fortgesetzt | DA Davidson | Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-05-24 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-23 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-02-09 | Herabstufung | Jefferies | Buy → Hold |
| 2023-02-02 | Eingeleitet | Raymond James | Outperform |
| 2022-09-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-05-02 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-04-29 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-29 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-29 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Eingeleitet | Wells Fargo | Underweight |
| 2022-04-07 | Eingeleitet | Guggenheim | Neutral |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-05-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-03-11 | Fortgesetzt | Goldman | Buy |
| 2021-01-15 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-07-27 | Eingeleitet | BofA Securities | Buy |
| 2020-07-27 | Eingeleitet | Credit Suisse | Neutral |
| 2020-07-27 | Eingeleitet | Goldman | Buy |
| 2020-07-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-27 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-07-27 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Accolade Inc Aktie (ACCD) Neueste Nachrichten
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (NasdaqACCD), Paragon 28, Inc. (NYSEFNA), Logility Supply Chain Solutions, Inc. (NasdaqLGTY), Enfusion, Inc. (NYSEENFN) - Morningstar
Accolade CFO Barnes sells shares worth $1,521 - MSN
Acclade CEO Rajeev Singh sells shares worth $8,103 - MSN
AcColade CFO Barnes sells shares worth $1,056 - MSN
Fairman Group LLC Has $6.16 Million Stake in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Accolade, Inc. (NASDAQ:ACCD) Sees Significant Decline in Short Interest - MarketBeat
Accolade president Robert Cavanaugh sells $1,735 in stock - MSN
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Accolade (NASDAQ:ACCD) Given "Equal Weight" Rating at Stephens - MarketBeat
Accolade president Robert Cavanaugh sells $1,735 in stock By Investing.com - Investing.com South Africa
Accolade CEO Rajeev Singh sells $3,504 in stock - MSN
Accolade CFO Barnes sells shares worth $1,521 By Investing.com - Investing.com Nigeria
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ENFN, VCSA, ACCD, AVAV - GlobeNewswire Inc.
Accolade CEO Rajeev Singh sells $3,504 in stock By Investing.com - Investing.com Australia
Brokerages Set Accolade, Inc. (NASDAQ:ACCD) PT at $7.55 - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerKAVL, VCSA, ACCD, AVAV - The Malaysian Reserve
Accolade president Robert Cavanaugh sells shares worth $3,857 By Investing.com - Investing.com Australia
Accolade president Robert Cavanaugh sells shares worth $3,857 - MSN
Accolade's EVP Richard Eskew sells $2,701 in stock - Investing.com India
Accolade's EVP Richard Eskew sells $2,701 in stock By Investing.com - Investing.com South Africa
Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering - PR Newswire
Accolade, Inc. (NASDAQ:ACCD) Short Interest Up 10.3% in January - MarketBeat
Accolade Sports Collection Review: A Retro Trip with Clunky Gameplay - imdb
Nisa Investment Advisors LLC Raises Holdings in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Why Accolade Inc (ACCD) Is Skyrocketing So Far In 2025 - Insider Monkey
Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock - MSN
Financial Analysis: Smart Powerr (NASDAQ:CREG) and Accolade (NASDAQ:ACCD) - Defense World
Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock By Investing.com - Investing.com South Africa
Accolade, Inc. (NASDAQ:ACCD) Short Interest Update - Defense World
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox - Benzinga
Cathie Wood’s ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock - Investing.com Nigeria
Halper Sadeh LLC Investigates Accolade, Inc. Sale to Transcarent for Fairness to Shareholders - HPBL
Nisa Investment Advisors LLC Buys 55,314 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
Investigation into Accolade Transaction with Transcarent: Potential Breach of Fiduciary Duty – Market - HPBL
Accolade Inc. (ACCD): Q3 2025 Earnings Preview and Stock Outlook – Market - HPBL
Geode Capital Management Increases Stake in Accolade, Inc. – Market - HPBL
Accolade Sports Collection takes a swing at Switch today - GoNintendo
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Accolade, Inc.ACCD - Victoria Advocate
Accolade (ACCD) Stock Update: Analyst Ratings and Market Performance – Market - HPBL
Finanzdaten der Accolade Inc-Aktie (ACCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
5.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):